
Avantor Inc. (AVTR) Stock Forecast & Price Target
Avantor Inc. (AVTR) Analyst Ratings
Bulls say
Avantor is a market leader in the rapidly growing biopharma and healthcare industries, providing essential products and services to aid in research and development for bringing life-saving drugs and treatments to market. The company has a strong global presence with diverse product offerings, and is poised to benefit from the anticipated growth in these industries. However, there are concerns around slowing organic growth and execution under new management, leading to a slightly discounted valuation compared to its peers in the life sciences industry. Investors should closely monitor the company's progress in meeting its guidance and driving future growth.
Bears say
Avantor is experiencing a turnaround, with its VWR segment driving positive organic growth ahead of expectations and demonstrating signs of operational improvement. However, the company is still facing challenges in its Bioscience Production segment, and its revenue and earnings forecasts are not fully de-risked. Additionally, Avantor faces competition from other large catalog providers, and its above-average level of debt and potential impacts from tariffs and geopolitical conflict could negatively impact its demand and margins. In order for Avantor to meet its targets and fully realize its growth potential, it will need to successfully execute its turnaround strategy and address its sustainability concerns.
This aggregate rating is based on analysts' research of Avantor Inc. and is not a guaranteed prediction by Public.com or investment advice.
Avantor Inc. (AVTR) Analyst Forecast & Price Prediction
Start investing in Avantor Inc. (AVTR)
Order type
Buy in
Order amount
Est. shares
0 shares